Lavaca Capital’s Diebold Nixdorf Incorporated DBD Stock Holding History

Lavaca Capital’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,083	Closed	-$12K	–	381
2019 Q1	$12K	Hold	1,083	–	–	0.01%	259
2018 Q4	$3K	Buy	+1,083	New	+$3.88K	﹤0.01%	324

Other funds holding DBD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Lavaca Capital's DBD Position: Q2 2019 in Review

Lavaca Capital sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2019, closing a stake of 1,083 shares — an estimated $12K sold.

Lavaca Capital first reported a position in DBD in Q4 2018 and held it in 2 quarters. The position peaked at $12K in Q1 2019. 198 funds tracked by Wall St. Rank hold DBD as of Q2 2019.

Lavaca Capital reported no remaining Diebold Nixdorf Incorporated position as of Q2 2019 after selling out during the quarter.
Lavaca Capital sold 1,083 Diebold Nixdorf Incorporated shares in Q2 2019, an estimated $12K.
Lavaca Capital first reported a position in Diebold Nixdorf Incorporated in Q4 2018 and held it in 2 quarters.
Lavaca Capital's Diebold Nixdorf Incorporated position peaked at $12K in Q1 2019.
198 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2019.

Based on Lavaca Capital's 13F filing for Q2 2019, filed 29 Jul 2019.